• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清学特征分析。

Serological characterization.

作者信息

Kuipers B, van den Dobbelsteen G, Wedege E, van Alphen L

机构信息

Laboratory of Vaccine Research, National Institute of Public Health and the Environment, Bilthoven, The Netherlands, Oslo, Norway.

出版信息

Methods Mol Med. 2001;67:131-45. doi: 10.1385/1-59259-149-3:131.

DOI:10.1385/1-59259-149-3:131
PMID:21337142
Abstract

Immunoassays employ a range of methods to detect and quantify antigens or antibodies and to study the composition of antigens. This chapter describes four useful immunoassays for serological characterization of antigens of Neisseria meningitidis: whole-cell enzyme-linked immunosorbent assay (ELISA); dot blot, colony blot, and immunoblot. Serological characterization of N. meningitidis antigens is valuable for epidemiological studies as well as for identifying immunologically important antigens in vaccine development (1,2). Typing of N. meningitidis is based on the immunological detection of specific epitopes on the outer-membrane proteins (OMP) and lipopolysaccharides (LPS) (3), and panels of monoclonal antibodies (MAbs) have been developed by several laboratories to refine the serological classification system (4-8). Differences in capsular polysaccharides determine the meningococcal serogroup, whereas the serotypes and serosubtypes are based on antigenic differences of the PorB OMP and PorA OMP, respectively (3). The PorA protein contains two variable loops (VR1 and VR2), each of which determine a dis- tinct set of serosubtypes. Thus the serosubtypes of an isolate can include two independent designations (9-11). Variation in the oligosaccharide moiety of the LPS determines the immunotype, and more than one epitope can be present in the same population of a single isolate (6,12). In the current typing scheme the classification is given as [serogroup]: [serotype]: [serosubtype]: [immunotype], e.g., B: 15:P1.7,16:L3,7,9.

摘要

免疫测定采用一系列方法来检测和定量抗原或抗体,并研究抗原的组成。本章描述了四种用于脑膜炎奈瑟菌抗原血清学特征分析的有用免疫测定方法:全细胞酶联免疫吸附测定(ELISA);斑点印迹、菌落印迹和免疫印迹。脑膜炎奈瑟菌抗原的血清学特征分析对于流行病学研究以及在疫苗开发中鉴定具有免疫学重要性的抗原都很有价值(1,2)。脑膜炎奈瑟菌的分型基于对外膜蛋白(OMP)和脂多糖(LPS)上特定表位的免疫检测(3),几个实验室已经开发了单克隆抗体(MAb)组来完善血清学分类系统(4 - 8)。荚膜多糖的差异决定了脑膜炎球菌的血清群,而血清型和血清亚型分别基于PorB OMP和PorA OMP的抗原差异(3)。PorA蛋白包含两个可变环(VR1和VR2),每个可变环决定一组不同的血清亚型。因此,分离株的血清亚型可以包括两个独立的命名(9 - 11)。LPS寡糖部分的变异决定了免疫型,并且在单个分离株的同一群体中可以存在不止一个表位(6,12)。在当前的分型方案中,分类表示为[血清群]:[血清型]:[血清亚型]:[免疫型],例如,B:15:P1.7,16:L3,7,9。

相似文献

1
Serological characterization.血清学特征分析。
Methods Mol Med. 2001;67:131-45. doi: 10.1385/1-59259-149-3:131.
2
Antigenic diversity of Neisseria meningitidis isolated in Taiwan between 1995 and 2002.1995年至2002年间台湾地区分离出的脑膜炎奈瑟菌的抗原多样性。
Scand J Infect Dis. 2006;38(4):273-80. doi: 10.1080/00365540500440379.
3
Phenotypic assessment of Neisseria meningitidis isolates obtained from patients with invasive meningococcal disease in Greece, 1993-2003: implications for serogroup B vaccines based on PorA serosubtype antigens.1993年至2003年希腊侵袭性脑膜炎球菌病患者分离出的脑膜炎奈瑟菌菌株的表型评估:基于PorA血清亚型抗原的B群疫苗的意义
Vaccine. 2006 Feb 6;24(6):819-25. doi: 10.1016/j.vaccine.2005.07.058. Epub 2005 Aug 8.
4
Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998.1992 - 1998年美国B群脑膜炎奈瑟菌中PorA类型的多样性与流行情况
J Infect Dis. 2000 Oct;182(4):1169-76. doi: 10.1086/315833. Epub 2000 Sep 8.
5
T cell recognition of Neisseria meningitidis class 1 outer membrane proteins. Identification of T cell epitopes with selected synthetic peptides and determination of HLA restriction elements.脑膜炎奈瑟菌1类外膜蛋白的T细胞识别。用选定的合成肽鉴定T细胞表位并确定HLA限制元件。
J Immunol. 1991 Sep 15;147(6):2012-8.
6
Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.针对脑膜炎奈瑟菌PorA的鼠单克隆抗体在幼鼠感染模型中对B:15:P1.7,16亚型变体的体内保护活性降低。
Microb Pathog. 2001 Mar;30(3):139-48. doi: 10.1006/mpat.2000.0419.
7
Construction of porA Mutants.porA突变体的构建
Methods Mol Med. 2001;66:145-54. doi: 10.1385/1-59259-148-5:145.
8
Lipopolysaccharide heterogeneity and escape mechanisms of Neisseria meningitidis: possible consequences for vaccine development.脑膜炎奈瑟菌的脂多糖异质性与逃逸机制:对疫苗研发的潜在影响
Microb Pathog. 1997 Sep;23(3):139-55. doi: 10.1006/mpat.1997.0143.
9
Induction of immune responses by purified outer membrane protein complexes from Neisseria meningitidis.脑膜炎奈瑟菌纯化外膜蛋白复合物诱导免疫应答。
Vaccine. 2012 Mar 16;30(13):2387-95. doi: 10.1016/j.vaccine.2011.08.123. Epub 2011 Sep 10.
10
[Serotyping and subtyping strains of Neisseria meningitidis isolated from patients in Czechoslovakia 1975-1986].[1975 - 1986年从捷克斯洛伐克患者中分离出的脑膜炎奈瑟菌菌株的血清分型和亚型分析]
Cesk Epidemiol Mikrobiol Imunol. 1990 Mar;39(2):78-87.

引用本文的文献

1
Genetic and antigenic analysis of invasive serogroup Y Neisseria meningitidis isolates collected from 1999 to 2003 in Canada.1999年至2003年在加拿大收集的侵袭性血清群Y脑膜炎奈瑟菌分离株的基因和抗原分析。
J Clin Microbiol. 2007 Jun;45(6):1753-8. doi: 10.1128/JCM.02134-06. Epub 2007 Apr 18.
2
Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.抗B、C、Y和W135群脑膜炎奈瑟菌的鼠杂交瘤单克隆抗体的血清学特异性及其作为血清分组试剂通过间接全细胞酶联免疫吸附测定法的效用评估。
Clin Diagn Lab Immunol. 2005 Jan;12(1):152-6. doi: 10.1128/CDLI.12.1.152-156.2005.
3
PorA variable regions of Neisseria meningitidis.脑膜炎奈瑟菌的PorA可变区
Emerg Infect Dis. 2004 Apr;10(4):674-8. doi: 10.3201/eid1004.030247.
4
Phenotypic and genetic characterization of a unique variant of serogroup C ET-15 meningococci (with the antigenic formula C:2a:P1.7,1) causing invasive meningococcal disease in Quebec, Canada.在加拿大魁北克引起侵袭性脑膜炎球菌病的C群ET-15脑膜炎球菌独特变体(抗原公式为C:2a:P1.7,1)的表型和基因特征
J Clin Microbiol. 2004 Apr;42(4):1460-5. doi: 10.1128/JCM.42.4.1460-1465.2004.
5
Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.冰岛青少年接种挪威B群脑膜炎球菌外膜囊泡疫苗后的抗体特异性及脑膜炎球菌携带情况的影响
Infect Immun. 2003 Jul;71(7):3775-81. doi: 10.1128/IAI.71.7.3775-3781.2003.
6
Cross-reactivity of antibodies against PorA after vaccination with a meningococcal B outer membrane vesicle vaccine.接种B群脑膜炎球菌外膜囊泡疫苗后针对PorA的抗体交叉反应性。
Infect Immun. 2003 Apr;71(4):1650-5. doi: 10.1128/IAI.71.4.1650-1655.2003.